Afsheen Raza
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 10
- Cancer Cells and Metastasis 3
- Co-authors
- Shahab Uddin (22 shared papers)Mohammad Haris (2 shared papers)Said Dermime (19 shared papers)Jean‐Charles Grivel (1 shared paper)Selma Maacha (1 shared paper)Lizandra Jimenez (1 shared paper)Ajaz A. Bhat (1 shared paper)Maysaloun Merhi (12 shared papers)
- Journals
- Malaria Journal (4 papers)Frontiers in Immunology (3 papers)Cancers (3 papers)Frontiers in Oncology (3 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- QatarPakistanUnited Arab Emirates
In The Last Decade
Afsheen Raza
52 papers receiving 1.4k citations
Afsheen Raza's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 403
- Infectious Diseases 226
- Immunology 241
- Molecular Biology 724
- Oncology 287
Countries citing papers authored by Afsheen Raza
This map shows the geographic impact of Afsheen Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsheen Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsheen Raza more than expected).
Fields of papers citing papers by Afsheen Raza
This network shows the impact of papers produced by Afsheen Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsheen Raza. The network helps show where Afsheen Raza may publish in the future.
Co-authors
The 25 scholars most cited alongside Afsheen Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance Hit paper breakdown → | 2019 | 406 |
| 2 | Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Hit paper breakdown → | 2022 | 261 |
| 3 | 2022 | 89 | |
| 4 | 2020 | 70 | |
| 5 | 2020 | 55 | |
| 6 | 2019 | 45 | |
| 7 | 2018 | 40 | |
| 8 | 2019 | 36 | |
| 9 | 2013 | 33 | |
| 10 | 2020 | 31 | |
| 11 | 2021 | 30 | |
| 12 | 2013 | 27 | |
| 13 | 2013 | 27 | |
| 14 | 2018 | 23 | |
| 15 | 2021 | 23 | |
| 16 | 2022 | 17 | |
| 17 | 2018 | 15 | |
| 18 | 2024 | 15 | |
| 19 | 2014 | 13 | |
| 20 | 2023 | 13 |
About Afsheen Raza
Afsheen Raza is a scholar working on Molecular Biology, Oncology, Immunology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Malaria Research and Control (9 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers), Mosquito-borne diseases and control (5 papers), Vector-borne infectious diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (403 citations), Infectious Diseases (226 citations), Immunology (241 citations), Molecular Biology (724 citations) and Oncology (287 citations). Afsheen Raza has collaborated with scholars based in Qatar, Pakistan and United Arab Emirates. Frequent co-authors include Shahab Uddin, Mohammad Haris, Said Dermime, Jean‐Charles Grivel, Selma Maacha, Lizandra Jimenez, Ajaz A. Bhat, Maysaloun Merhi, Varghese Inchakalody and Queenie Fernandes. Their work appears in journals such as Malaria Journal, Frontiers in Immunology, Cancers, Frontiers in Oncology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.